ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Public Health Service: Blumenthal Transferred to Surgeon General’s office, HHS Says

November 7, 1997

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Large Studies Show Promising Results For Targeted Therapies Alimta, Tarceva

June 26, 2009

NCI-Approved Clinical Trials

May 26, 2006

NCAB Subcommittee Tells Califano To Keep Hands Off Board Appointments

May 18, 1979

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978